Kapa Biosystems Expands Partnership With Roche NimbleGen, Inc To Include RNA Sample Preparation For Targeted Next-Gen Sequencing

WILMINGTON, Mass.--(BUSINESS WIRE)--Kapa Biosystems, Inc. today announced an expanded partnership with Roche NimbleGen to include new, optimized, RNA sample-preparation methods for targeted RNA next-generation sequencing (NGS) applications. Kapa Biosystems will custom manufacture versions of its KAPA Stranded RNA-Seq Kits for Roche NimbleGen to distribute with its recently launched SeqCap RNA Target Enrichment System.

The new offering combines KAPA Stranded RNA-Seq Kits with Roche NimbleGen’s SeqCap RNA Target Enrichment System for complete workflow coverage prior to sequencing. This validated protocol provides customers with a high-resolution view of the transcriptome and the ability to work with a wide range of RNA input, starting as low as 10 ng. Compared to other workflows, this offering provides precise measurement of strand orientation (>99%), uniform coverage, and high-confidence mapping of alternate transcripts. It is also optimized for the improved coverage of GC-rich and low-abundance transcripts. The Roche NimbleGen SeqCap RNA System can be used to evaluate different populations of RNA, including total RNA and non-coding RNA.

Help employers find you! Check out all the jobs and post your resume.

Back to news